nodes	percent_of_prediction	percent_of_DWPC	metapath
L-Arginine—NOS3—breast cancer	0.237	0.509	CbGaD
L-Arginine—NOS2—breast cancer	0.229	0.491	CbGaD
L-Arginine—NOS3—Doxorubicin—breast cancer	0.102	0.5	CbGbCtD
L-Arginine—NOS2—Doxorubicin—breast cancer	0.102	0.5	CbGbCtD
L-Arginine—NOS3—umbilical vein—breast cancer	0.00441	0.0543	CbGeAlD
L-Arginine—ASL—mammary gland—breast cancer	0.0043	0.053	CbGeAlD
L-Arginine—NOS2—adrenal gland—breast cancer	0.00246	0.0304	CbGeAlD
L-Arginine—ARG2—mammary gland—breast cancer	0.00241	0.0297	CbGeAlD
L-Arginine—AZIN2—pituitary gland—breast cancer	0.00209	0.0257	CbGeAlD
L-Arginine—AZIN2—adipose tissue—breast cancer	0.00208	0.0256	CbGeAlD
L-Arginine—SLC7A4—female reproductive system—breast cancer	0.002	0.0246	CbGeAlD
L-Arginine—ASL—uterus—breast cancer	0.00198	0.0244	CbGeAlD
L-Arginine—ASL—adipose tissue—breast cancer	0.00194	0.0238	CbGeAlD
L-Arginine—AZIN2—adrenal gland—breast cancer	0.00187	0.023	CbGeAlD
L-Arginine—ASL—female reproductive system—breast cancer	0.00178	0.0219	CbGeAlD
L-Arginine—AZIN2—female gonad—breast cancer	0.00174	0.0214	CbGeAlD
L-Arginine—ASL—adrenal gland—breast cancer	0.00174	0.0214	CbGeAlD
L-Arginine—ASS1—mammary gland—breast cancer	0.00169	0.0208	CbGeAlD
L-Arginine—NOS3—mammary gland—breast cancer	0.00168	0.0207	CbGeAlD
L-Arginine—ASL—female gonad—breast cancer	0.00162	0.0199	CbGeAlD
L-Arginine—ASL—endocrine gland—breast cancer	0.00151	0.0185	CbGeAlD
L-Arginine—ASS1—Norethindrone—Fluoxymesterone—breast cancer	0.0014	1	CbGdCrCtD
L-Arginine—ASS1—nipple—breast cancer	0.0014	0.0172	CbGeAlD
L-Arginine—ARG2—epithelium—breast cancer	0.00134	0.0165	CbGeAlD
L-Arginine—SLC7A1—uterus—breast cancer	0.0013	0.016	CbGeAlD
L-Arginine—SLC7A1—adipose tissue—breast cancer	0.00127	0.0156	CbGeAlD
L-Arginine—ARG2—endometrium—breast cancer	0.0012	0.0148	CbGeAlD
L-Arginine—SLC7A1—female reproductive system—breast cancer	0.00117	0.0144	CbGeAlD
L-Arginine—SLC7A1—adrenal gland—breast cancer	0.00114	0.014	CbGeAlD
L-Arginine—AZIN2—lymph node—breast cancer	0.00112	0.0138	CbGeAlD
L-Arginine—ARG2—uterus—breast cancer	0.00111	0.0137	CbGeAlD
L-Arginine—ARG2—pituitary gland—breast cancer	0.00109	0.0134	CbGeAlD
L-Arginine—ARG2—adipose tissue—breast cancer	0.00109	0.0134	CbGeAlD
L-Arginine—SLC22A4—mammary gland—breast cancer	0.00108	0.0132	CbGeAlD
L-Arginine—SLC7A1—female gonad—breast cancer	0.00106	0.0131	CbGeAlD
L-Arginine—ASL—lymph node—breast cancer	0.00104	0.0128	CbGeAlD
L-Arginine—SLC16A10—nipple—breast cancer	0.000999	0.0123	CbGeAlD
L-Arginine—ARG2—female reproductive system—breast cancer	0.000998	0.0123	CbGeAlD
L-Arginine—SLC7A1—endocrine gland—breast cancer	0.000987	0.0122	CbGeAlD
L-Arginine—ARG2—adrenal gland—breast cancer	0.000974	0.012	CbGeAlD
L-Arginine—ASS1—epithelium—breast cancer	0.000941	0.0116	CbGeAlD
L-Arginine—NOS3—epithelium—breast cancer	0.000938	0.0116	CbGeAlD
L-Arginine—ARG2—female gonad—breast cancer	0.000908	0.0112	CbGeAlD
L-Arginine—ASS1—skin of body—breast cancer	0.000895	0.011	CbGeAlD
L-Arginine—L-Glutamine—TGM2—breast cancer	0.000866	0.303	CrCbGaD
L-Arginine—L-Methionine—MTR—breast cancer	0.000855	0.299	CrCbGaD
L-Arginine—ARG2—endocrine gland—breast cancer	0.000844	0.0104	CbGeAlD
L-Arginine—ASS1—endometrium—breast cancer	0.000844	0.0104	CbGeAlD
L-Arginine—ASS1—uterus—breast cancer	0.000778	0.00958	CbGeAlD
L-Arginine—ASS1—pituitary gland—breast cancer	0.000764	0.00941	CbGeAlD
L-Arginine—ASS1—adipose tissue—breast cancer	0.000761	0.00937	CbGeAlD
L-Arginine—SLC22A5—mammary gland—breast cancer	0.000712	0.00876	CbGeAlD
L-Arginine—ASS1—female reproductive system—breast cancer	0.000699	0.00861	CbGeAlD
L-Arginine—NOS3—female reproductive system—breast cancer	0.000697	0.00858	CbGeAlD
L-Arginine—ASS1—adrenal gland—breast cancer	0.000682	0.0084	CbGeAlD
L-Arginine—SLC7A1—lymph node—breast cancer	0.000682	0.0084	CbGeAlD
L-Arginine—NOS3—adrenal gland—breast cancer	0.00068	0.00838	CbGeAlD
L-Arginine—SLC16A10—epithelium—breast cancer	0.000672	0.00828	CbGeAlD
L-Arginine—ASS1—female gonad—breast cancer	0.000636	0.00783	CbGeAlD
L-Arginine—ASS1—endocrine gland—breast cancer	0.000592	0.00729	CbGeAlD
L-Arginine—NOS3—endocrine gland—breast cancer	0.00059	0.00726	CbGeAlD
L-Arginine—SLC22A5—nipple—breast cancer	0.000589	0.00725	CbGeAlD
L-Arginine—ARG2—lymph node—breast cancer	0.000584	0.00719	CbGeAlD
L-Arginine—SLC16A10—adipose tissue—breast cancer	0.000543	0.00669	CbGeAlD
L-Arginine—SLC22A4—endometrium—breast cancer	0.000537	0.00661	CbGeAlD
L-Arginine—SLC16A10—female reproductive system—breast cancer	0.0005	0.00615	CbGeAlD
L-Arginine—SLC22A4—pituitary gland—breast cancer	0.000486	0.00598	CbGeAlD
L-Arginine—SLC22A4—adipose tissue—breast cancer	0.000484	0.00596	CbGeAlD
L-Arginine—SLC22A4—female reproductive system—breast cancer	0.000445	0.00548	CbGeAlD
L-Arginine—SLC22A4—adrenal gland—breast cancer	0.000434	0.00535	CbGeAlD
L-Arginine—L-Citrulline—NOS3—breast cancer	0.000429	0.15	CrCbGaD
L-Arginine—SLC16A10—endocrine gland—breast cancer	0.000423	0.00521	CbGeAlD
L-Arginine—SLC22A4—bone marrow—breast cancer	0.00042	0.00517	CbGeAlD
L-Arginine—L-Citrulline—NOS2—breast cancer	0.000414	0.145	CrCbGaD
L-Arginine—ASS1—lymph node—breast cancer	0.000409	0.00504	CbGeAlD
L-Arginine—NOS3—lymph node—breast cancer	0.000408	0.00502	CbGeAlD
L-Arginine—SLC22A5—skin of body—breast cancer	0.000377	0.00464	CbGeAlD
L-Arginine—SLC22A5—endometrium—breast cancer	0.000355	0.00438	CbGeAlD
L-Arginine—SLC22A5—pituitary gland—breast cancer	0.000322	0.00396	CbGeAlD
L-Arginine—SLC22A5—adipose tissue—breast cancer	0.00032	0.00394	CbGeAlD
L-Arginine—SLC22A5—female reproductive system—breast cancer	0.000294	0.00363	CbGeAlD
L-Arginine—L-Methionine—MTHFR—breast cancer	0.000292	0.102	CrCbGaD
L-Arginine—SLC16A10—lymph node—breast cancer	0.000292	0.0036	CbGeAlD
L-Arginine—SLC22A5—adrenal gland—breast cancer	0.000287	0.00354	CbGeAlD
L-Arginine—Vomiting—Fulvestrant—breast cancer	0.000281	0.00242	CcSEcCtD
L-Arginine—Hypoaesthesia—Vinorelbine—breast cancer	0.00028	0.00241	CcSEcCtD
L-Arginine—Lethargy—Paclitaxel—breast cancer	0.000279	0.0024	CcSEcCtD
L-Arginine—Rash—Fulvestrant—breast cancer	0.000279	0.0024	CcSEcCtD
L-Arginine—Dermatitis—Fulvestrant—breast cancer	0.000278	0.0024	CcSEcCtD
L-Arginine—Vomiting—Toremifene—breast cancer	0.000277	0.00239	CcSEcCtD
L-Arginine—Headache—Fulvestrant—breast cancer	0.000277	0.00238	CcSEcCtD
L-Arginine—Rash—Toremifene—breast cancer	0.000275	0.00237	CcSEcCtD
L-Arginine—Dermatitis—Toremifene—breast cancer	0.000275	0.00237	CcSEcCtD
L-Arginine—Necrosis—Epirubicin—breast cancer	0.000274	0.00236	CcSEcCtD
L-Arginine—Headache—Toremifene—breast cancer	0.000273	0.00235	CcSEcCtD
L-Arginine—SLC22A5—female gonad—breast cancer	0.000268	0.0033	CbGeAlD
L-Arginine—Hypersensitivity—Ixabepilone—breast cancer	0.000267	0.0023	CcSEcCtD
L-Arginine—Extravasation—Methotrexate—breast cancer	0.000263	0.00227	CcSEcCtD
L-Arginine—Swelling—Docetaxel—breast cancer	0.000262	0.00226	CcSEcCtD
L-Arginine—Nausea—Fulvestrant—breast cancer	0.000262	0.00226	CcSEcCtD
L-Arginine—Flushing—Vinorelbine—breast cancer	0.000261	0.00225	CcSEcCtD
L-Arginine—SLC22A4—lymph node—breast cancer	0.00026	0.0032	CbGeAlD
L-Arginine—Nausea—Toremifene—breast cancer	0.000259	0.00223	CcSEcCtD
L-Arginine—Swelling—Capecitabine—breast cancer	0.000254	0.00219	CcSEcCtD
L-Arginine—Necrosis—Doxorubicin—breast cancer	0.000254	0.00218	CcSEcCtD
L-Arginine—Hypersensitivity—Anastrozole—breast cancer	0.000251	0.00216	CcSEcCtD
L-Arginine—Anorexia—Chlorambucil—breast cancer	0.00025	0.00215	CcSEcCtD
L-Arginine—Sweating—Irinotecan—breast cancer	0.000247	0.00213	CcSEcCtD
L-Arginine—Sweating—Mitoxantrone—breast cancer	0.000247	0.00213	CcSEcCtD
L-Arginine—Extravasation—Epirubicin—breast cancer	0.000247	0.00212	CcSEcCtD
L-Arginine—Haematuria—Mitoxantrone—breast cancer	0.000246	0.00212	CcSEcCtD
L-Arginine—Vomiting—Exemestane—breast cancer	0.000244	0.0021	CcSEcCtD
L-Arginine—Rash—Exemestane—breast cancer	0.000242	0.00208	CcSEcCtD
L-Arginine—Dermatitis—Exemestane—breast cancer	0.000242	0.00208	CcSEcCtD
L-Arginine—Sweating—Gemcitabine—breast cancer	0.000241	0.00208	CcSEcCtD
L-Arginine—Headache—Exemestane—breast cancer	0.00024	0.00207	CcSEcCtD
L-Arginine—Haematuria—Gemcitabine—breast cancer	0.00024	0.00207	CcSEcCtD
L-Arginine—Hypersensitivity—Idarubicin—breast cancer	0.000238	0.00205	CcSEcCtD
L-Arginine—Lethargy—Docetaxel—breast cancer	0.000236	0.00204	CcSEcCtD
L-Arginine—Vomiting—Ixabepilone—breast cancer	0.00023	0.00198	CcSEcCtD
L-Arginine—Anorexia—Vinblastine—breast cancer	0.000229	0.00197	CcSEcCtD
L-Arginine—Lethargy—Capecitabine—breast cancer	0.000229	0.00197	CcSEcCtD
L-Arginine—Anaphylactic shock—Melphalan—breast cancer	0.000228	0.00197	CcSEcCtD
L-Arginine—Rash—Ixabepilone—breast cancer	0.000228	0.00197	CcSEcCtD
L-Arginine—Extravasation—Doxorubicin—breast cancer	0.000228	0.00197	CcSEcCtD
L-Arginine—Dermatitis—Ixabepilone—breast cancer	0.000228	0.00197	CcSEcCtD
L-Arginine—Nausea—Exemestane—breast cancer	0.000228	0.00196	CcSEcCtD
L-Arginine—Decreased appetite—Chlorambucil—breast cancer	0.000228	0.00196	CcSEcCtD
L-Arginine—Headache—Ixabepilone—breast cancer	0.000227	0.00195	CcSEcCtD
L-Arginine—Hyperhidrosis—Tamoxifen—breast cancer	0.000226	0.00194	CcSEcCtD
L-Arginine—Tachycardia—Melphalan—breast cancer	0.000223	0.00192	CcSEcCtD
L-Arginine—Anaphylactic shock—Goserelin—breast cancer	0.000223	0.00192	CcSEcCtD
L-Arginine—Anorexia—Tamoxifen—breast cancer	0.000222	0.00192	CcSEcCtD
L-Arginine—Hypoaesthesia—Fluorouracil—breast cancer	0.000221	0.0019	CcSEcCtD
L-Arginine—Skin exfoliation—Methotrexate—breast cancer	0.000219	0.00189	CcSEcCtD
L-Arginine—Anorexia—Melphalan—breast cancer	0.000218	0.00188	CcSEcCtD
L-Arginine—Tachycardia—Goserelin—breast cancer	0.000218	0.00187	CcSEcCtD
L-Arginine—Vomiting—Letrozole—breast cancer	0.000217	0.00187	CcSEcCtD
L-Arginine—Vomiting—Anastrozole—breast cancer	0.000217	0.00187	CcSEcCtD
L-Arginine—Hyperhidrosis—Goserelin—breast cancer	0.000215	0.00186	CcSEcCtD
L-Arginine—Nausea—Ixabepilone—breast cancer	0.000215	0.00185	CcSEcCtD
L-Arginine—Flushing—Irinotecan—breast cancer	0.000215	0.00185	CcSEcCtD
L-Arginine—Rash—Anastrozole—breast cancer	0.000215	0.00185	CcSEcCtD
L-Arginine—Rash—Letrozole—breast cancer	0.000215	0.00185	CcSEcCtD
L-Arginine—Dermatitis—Anastrozole—breast cancer	0.000215	0.00185	CcSEcCtD
L-Arginine—Dermatitis—Letrozole—breast cancer	0.000215	0.00185	CcSEcCtD
L-Arginine—Injection site reaction—Epirubicin—breast cancer	0.000214	0.00184	CcSEcCtD
L-Arginine—Headache—Anastrozole—breast cancer	0.000214	0.00184	CcSEcCtD
L-Arginine—Headache—Letrozole—breast cancer	0.000214	0.00184	CcSEcCtD
L-Arginine—Anorexia—Goserelin—breast cancer	0.000212	0.00183	CcSEcCtD
L-Arginine—Decreased appetite—Vinblastine—breast cancer	0.000209	0.0018	CcSEcCtD
L-Arginine—Vomiting—Idarubicin—breast cancer	0.000206	0.00177	CcSEcCtD
L-Arginine—Vomiting—Raloxifene—breast cancer	0.000206	0.00177	CcSEcCtD
L-Arginine—Skin exfoliation—Epirubicin—breast cancer	0.000205	0.00177	CcSEcCtD
L-Arginine—Rash—Raloxifene—breast cancer	0.000204	0.00176	CcSEcCtD
L-Arginine—Rash—Idarubicin—breast cancer	0.000204	0.00176	CcSEcCtD
L-Arginine—Dermatitis—Idarubicin—breast cancer	0.000204	0.00176	CcSEcCtD
L-Arginine—Dermatitis—Raloxifene—breast cancer	0.000204	0.00176	CcSEcCtD
L-Arginine—Decreased appetite—Tamoxifen—breast cancer	0.000203	0.00175	CcSEcCtD
L-Arginine—Headache—Raloxifene—breast cancer	0.000203	0.00175	CcSEcCtD
L-Arginine—Headache—Idarubicin—breast cancer	0.000203	0.00175	CcSEcCtD
L-Arginine—Nausea—Letrozole—breast cancer	0.000203	0.00174	CcSEcCtD
L-Arginine—Nausea—Anastrozole—breast cancer	0.000203	0.00174	CcSEcCtD
L-Arginine—Haematuria—Paclitaxel—breast cancer	0.000201	0.00173	CcSEcCtD
L-Arginine—Anaphylactic shock—Vinorelbine—breast cancer	0.0002	0.00172	CcSEcCtD
L-Arginine—Decreased appetite—Melphalan—breast cancer	0.000199	0.00171	CcSEcCtD
L-Arginine—Injection site reaction—Doxorubicin—breast cancer	0.000198	0.0017	CcSEcCtD
L-Arginine—Tachycardia—Vinorelbine—breast cancer	0.000195	0.00168	CcSEcCtD
L-Arginine—Decreased appetite—Goserelin—breast cancer	0.000194	0.00167	CcSEcCtD
L-Arginine—Hypersensitivity—Chlorambucil—breast cancer	0.000193	0.00166	CcSEcCtD
L-Arginine—Nausea—Idarubicin—breast cancer	0.000192	0.00166	CcSEcCtD
L-Arginine—Nausea—Raloxifene—breast cancer	0.000192	0.00166	CcSEcCtD
L-Arginine—Anorexia—Vinorelbine—breast cancer	0.00019	0.00164	CcSEcCtD
L-Arginine—Skin exfoliation—Doxorubicin—breast cancer	0.00019	0.00164	CcSEcCtD
L-Arginine—Hypoaesthesia—Paclitaxel—breast cancer	0.000188	0.00162	CcSEcCtD
L-Arginine—Tachycardia—Thiotepa—breast cancer	0.000186	0.0016	CcSEcCtD
L-Arginine—Anorexia—Thiotepa—breast cancer	0.000182	0.00157	CcSEcCtD
L-Arginine—Hypersensitivity—Vinblastine—breast cancer	0.000177	0.00152	CcSEcCtD
L-Arginine—Flushing—Paclitaxel—breast cancer	0.000175	0.00151	CcSEcCtD
L-Arginine—Decreased appetite—Vinorelbine—breast cancer	0.000174	0.00149	CcSEcCtD
L-Arginine—SLC22A5—lymph node—breast cancer	0.000172	0.00212	CbGeAlD
L-Arginine—Hypersensitivity—Tamoxifen—breast cancer	0.000172	0.00148	CcSEcCtD
L-Arginine—Lethargy—Methotrexate—breast cancer	0.00017	0.00147	CcSEcCtD
L-Arginine—Hypersensitivity—Melphalan—breast cancer	0.000168	0.00145	CcSEcCtD
L-Arginine—Vomiting—Chlorambucil—breast cancer	0.000167	0.00144	CcSEcCtD
L-Arginine—Decreased appetite—Thiotepa—breast cancer	0.000166	0.00143	CcSEcCtD
L-Arginine—Haematuria—Capecitabine—breast cancer	0.000165	0.00142	CcSEcCtD
L-Arginine—Anaphylactic shock—Irinotecan—breast cancer	0.000165	0.00142	CcSEcCtD
L-Arginine—Anaphylactic shock—Mitoxantrone—breast cancer	0.000165	0.00142	CcSEcCtD
L-Arginine—Hypersensitivity—Goserelin—breast cancer	0.000164	0.00141	CcSEcCtD
L-Arginine—Tachycardia—Mitoxantrone—breast cancer	0.000161	0.00138	CcSEcCtD
L-Arginine—Anaphylactic shock—Gemcitabine—breast cancer	0.00016	0.00138	CcSEcCtD
L-Arginine—Hypoaesthesia—Docetaxel—breast cancer	0.000159	0.00137	CcSEcCtD
L-Arginine—Lethargy—Epirubicin—breast cancer	0.000159	0.00137	CcSEcCtD
L-Arginine—Hyperhidrosis—Irinotecan—breast cancer	0.000159	0.00137	CcSEcCtD
L-Arginine—Hyperhidrosis—Mitoxantrone—breast cancer	0.000159	0.00137	CcSEcCtD
L-Arginine—Anaphylactic shock—Fluorouracil—breast cancer	0.000158	0.00136	CcSEcCtD
L-Arginine—Anorexia—Irinotecan—breast cancer	0.000157	0.00135	CcSEcCtD
L-Arginine—Anorexia—Mitoxantrone—breast cancer	0.000157	0.00135	CcSEcCtD
L-Arginine—Nausea—Chlorambucil—breast cancer	0.000156	0.00134	CcSEcCtD
L-Arginine—Hyperhidrosis—Gemcitabine—breast cancer	0.000155	0.00134	CcSEcCtD
L-Arginine—Hypoaesthesia—Capecitabine—breast cancer	0.000154	0.00133	CcSEcCtD
L-Arginine—Tachycardia—Fluorouracil—breast cancer	0.000154	0.00133	CcSEcCtD
L-Arginine—Anorexia—Gemcitabine—breast cancer	0.000153	0.00132	CcSEcCtD
L-Arginine—Vomiting—Vinblastine—breast cancer	0.000153	0.00132	CcSEcCtD
L-Arginine—Headache—Vinblastine—breast cancer	0.00015	0.0013	CcSEcCtD
L-Arginine—Anorexia—Fluorouracil—breast cancer	0.00015	0.00129	CcSEcCtD
L-Arginine—Flushing—Docetaxel—breast cancer	0.000149	0.00128	CcSEcCtD
L-Arginine—Vomiting—Tamoxifen—breast cancer	0.000148	0.00128	CcSEcCtD
L-Arginine—Lethargy—Doxorubicin—breast cancer	0.000147	0.00127	CcSEcCtD
L-Arginine—Rash—Tamoxifen—breast cancer	0.000147	0.00127	CcSEcCtD
L-Arginine—Hypersensitivity—Vinorelbine—breast cancer	0.000147	0.00127	CcSEcCtD
L-Arginine—Dermatitis—Tamoxifen—breast cancer	0.000147	0.00127	CcSEcCtD
L-Arginine—Headache—Tamoxifen—breast cancer	0.000146	0.00126	CcSEcCtD
L-Arginine—Vomiting—Melphalan—breast cancer	0.000145	0.00125	CcSEcCtD
L-Arginine—Rash—Melphalan—breast cancer	0.000144	0.00124	CcSEcCtD
L-Arginine—Flushing—Capecitabine—breast cancer	0.000144	0.00124	CcSEcCtD
L-Arginine—Dermatitis—Melphalan—breast cancer	0.000144	0.00124	CcSEcCtD
L-Arginine—Decreased appetite—Irinotecan—breast cancer	0.000143	0.00123	CcSEcCtD
L-Arginine—Decreased appetite—Mitoxantrone—breast cancer	0.000143	0.00123	CcSEcCtD
L-Arginine—Nausea—Vinblastine—breast cancer	0.000143	0.00123	CcSEcCtD
L-Arginine—Vomiting—Goserelin—breast cancer	0.000142	0.00122	CcSEcCtD
L-Arginine—Rash—Goserelin—breast cancer	0.000141	0.00121	CcSEcCtD
L-Arginine—Hypersensitivity—Thiotepa—breast cancer	0.00014	0.00121	CcSEcCtD
L-Arginine—Dermatitis—Goserelin—breast cancer	0.00014	0.00121	CcSEcCtD
L-Arginine—Headache—Goserelin—breast cancer	0.00014	0.0012	CcSEcCtD
L-Arginine—Decreased appetite—Gemcitabine—breast cancer	0.000139	0.0012	CcSEcCtD
L-Arginine—Nausea—Tamoxifen—breast cancer	0.000139	0.00119	CcSEcCtD
L-Arginine—Decreased appetite—Fluorouracil—breast cancer	0.000137	0.00118	CcSEcCtD
L-Arginine—Nausea—Melphalan—breast cancer	0.000136	0.00117	CcSEcCtD
L-Arginine—Anaphylactic shock—Paclitaxel—breast cancer	0.000134	0.00116	CcSEcCtD
L-Arginine—Nausea—Goserelin—breast cancer	0.000132	0.00114	CcSEcCtD
L-Arginine—Tachycardia—Paclitaxel—breast cancer	0.000131	0.00113	CcSEcCtD
L-Arginine—Hyperhidrosis—Paclitaxel—breast cancer	0.00013	0.00112	CcSEcCtD
L-Arginine—Anorexia—Paclitaxel—breast cancer	0.000128	0.0011	CcSEcCtD
L-Arginine—Vomiting—Vinorelbine—breast cancer	0.000127	0.00109	CcSEcCtD
L-Arginine—Rash—Vinorelbine—breast cancer	0.000126	0.00108	CcSEcCtD
L-Arginine—Dermatitis—Vinorelbine—breast cancer	0.000126	0.00108	CcSEcCtD
L-Arginine—Headache—Vinorelbine—breast cancer	0.000125	0.00108	CcSEcCtD
L-Arginine—Sweating—Methotrexate—breast cancer	0.000123	0.00106	CcSEcCtD
L-Arginine—Haematuria—Methotrexate—breast cancer	0.000123	0.00106	CcSEcCtD
L-Arginine—Hypersensitivity—Irinotecan—breast cancer	0.000121	0.00104	CcSEcCtD
L-Arginine—Hypersensitivity—Mitoxantrone—breast cancer	0.000121	0.00104	CcSEcCtD
L-Arginine—Vomiting—Thiotepa—breast cancer	0.000121	0.00104	CcSEcCtD
L-Arginine—Rash—Thiotepa—breast cancer	0.00012	0.00104	CcSEcCtD
L-Arginine—Dermatitis—Thiotepa—breast cancer	0.00012	0.00103	CcSEcCtD
L-Arginine—Headache—Thiotepa—breast cancer	0.000119	0.00103	CcSEcCtD
L-Arginine—Nausea—Vinorelbine—breast cancer	0.000119	0.00102	CcSEcCtD
L-Arginine—Decreased appetite—Paclitaxel—breast cancer	0.000117	0.00101	CcSEcCtD
L-Arginine—Hypersensitivity—Fluorouracil—breast cancer	0.000116	0.001	CcSEcCtD
L-Arginine—Sweating—Epirubicin—breast cancer	0.000115	0.000994	CcSEcCtD
L-Arginine—Haematuria—Epirubicin—breast cancer	0.000115	0.000989	CcSEcCtD
L-Arginine—Anaphylactic shock—Docetaxel—breast cancer	0.000114	0.00098	CcSEcCtD
L-Arginine—Nausea—Thiotepa—breast cancer	0.000113	0.000975	CcSEcCtD
L-Arginine—Tachycardia—Docetaxel—breast cancer	0.000111	0.000957	CcSEcCtD
L-Arginine—Anorexia—Docetaxel—breast cancer	0.000108	0.000934	CcSEcCtD
L-Arginine—Tachycardia—Capecitabine—breast cancer	0.000108	0.000926	CcSEcCtD
L-Arginine—Hypoaesthesia—Epirubicin—breast cancer	0.000107	0.000926	CcSEcCtD
L-Arginine—Sweating—Doxorubicin—breast cancer	0.000107	0.00092	CcSEcCtD
L-Arginine—Hyperhidrosis—Capecitabine—breast cancer	0.000107	0.000918	CcSEcCtD
L-Arginine—Haematuria—Doxorubicin—breast cancer	0.000106	0.000915	CcSEcCtD
L-Arginine—Anorexia—Capecitabine—breast cancer	0.000105	0.000905	CcSEcCtD
L-Arginine—Vomiting—Mitoxantrone—breast cancer	0.000105	0.000902	CcSEcCtD
L-Arginine—Vomiting—Irinotecan—breast cancer	0.000105	0.000902	CcSEcCtD
L-Arginine—Rash—Irinotecan—breast cancer	0.000104	0.000894	CcSEcCtD
L-Arginine—Rash—Mitoxantrone—breast cancer	0.000104	0.000894	CcSEcCtD
L-Arginine—Dermatitis—Mitoxantrone—breast cancer	0.000104	0.000893	CcSEcCtD
L-Arginine—Dermatitis—Irinotecan—breast cancer	0.000104	0.000893	CcSEcCtD
L-Arginine—Headache—Mitoxantrone—breast cancer	0.000103	0.000888	CcSEcCtD
L-Arginine—Headache—Irinotecan—breast cancer	0.000103	0.000888	CcSEcCtD
L-Arginine—Vomiting—Gemcitabine—breast cancer	0.000102	0.000878	CcSEcCtD
L-Arginine—Rash—Gemcitabine—breast cancer	0.000101	0.000871	CcSEcCtD
L-Arginine—Dermatitis—Gemcitabine—breast cancer	0.000101	0.00087	CcSEcCtD
L-Arginine—Headache—Gemcitabine—breast cancer	0.0001	0.000865	CcSEcCtD
L-Arginine—Flushing—Epirubicin—breast cancer	0.0001	0.000864	CcSEcCtD
L-Arginine—Vomiting—Fluorouracil—breast cancer	0.0001	0.000864	CcSEcCtD
L-Arginine—Hypoaesthesia—Doxorubicin—breast cancer	9.95e-05	0.000857	CcSEcCtD
L-Arginine—Rash—Fluorouracil—breast cancer	9.94e-05	0.000856	CcSEcCtD
L-Arginine—Dermatitis—Fluorouracil—breast cancer	9.93e-05	0.000856	CcSEcCtD
L-Arginine—Decreased appetite—Docetaxel—breast cancer	9.89e-05	0.000852	CcSEcCtD
L-Arginine—Hypersensitivity—Paclitaxel—breast cancer	9.89e-05	0.000852	CcSEcCtD
L-Arginine—Headache—Fluorouracil—breast cancer	9.88e-05	0.000851	CcSEcCtD
L-Arginine—Nausea—Irinotecan—breast cancer	9.78e-05	0.000842	CcSEcCtD
L-Arginine—Nausea—Mitoxantrone—breast cancer	9.78e-05	0.000842	CcSEcCtD
L-Arginine—Decreased appetite—Capecitabine—breast cancer	9.58e-05	0.000825	CcSEcCtD
L-Arginine—Nausea—Gemcitabine—breast cancer	9.52e-05	0.000821	CcSEcCtD
L-Arginine—Nausea—Fluorouracil—breast cancer	9.37e-05	0.000807	CcSEcCtD
L-Arginine—Flushing—Doxorubicin—breast cancer	9.28e-05	0.000799	CcSEcCtD
L-Arginine—Vomiting—Paclitaxel—breast cancer	8.54e-05	0.000735	CcSEcCtD
L-Arginine—Rash—Paclitaxel—breast cancer	8.47e-05	0.000729	CcSEcCtD
L-Arginine—Dermatitis—Paclitaxel—breast cancer	8.46e-05	0.000729	CcSEcCtD
L-Arginine—Headache—Paclitaxel—breast cancer	8.41e-05	0.000725	CcSEcCtD
L-Arginine—Hypersensitivity—Docetaxel—breast cancer	8.38e-05	0.000722	CcSEcCtD
L-Arginine—Anaphylactic shock—Methotrexate—breast cancer	8.2e-05	0.000707	CcSEcCtD
L-Arginine—Hypersensitivity—Capecitabine—breast cancer	8.12e-05	0.000699	CcSEcCtD
L-Arginine—Nausea—Paclitaxel—breast cancer	7.97e-05	0.000687	CcSEcCtD
L-Arginine—Hyperhidrosis—Methotrexate—breast cancer	7.93e-05	0.000683	CcSEcCtD
L-Arginine—Anorexia—Methotrexate—breast cancer	7.82e-05	0.000674	CcSEcCtD
L-Arginine—Anaphylactic shock—Epirubicin—breast cancer	7.68e-05	0.000661	CcSEcCtD
L-Arginine—Tachycardia—Epirubicin—breast cancer	7.49e-05	0.000645	CcSEcCtD
L-Arginine—Hyperhidrosis—Epirubicin—breast cancer	7.42e-05	0.000639	CcSEcCtD
L-Arginine—Anorexia—Epirubicin—breast cancer	7.32e-05	0.00063	CcSEcCtD
L-Arginine—Vomiting—Docetaxel—breast cancer	7.24e-05	0.000623	CcSEcCtD
L-Arginine—Rash—Docetaxel—breast cancer	7.18e-05	0.000618	CcSEcCtD
L-Arginine—Dermatitis—Docetaxel—breast cancer	7.17e-05	0.000618	CcSEcCtD
L-Arginine—Decreased appetite—Methotrexate—breast cancer	7.13e-05	0.000614	CcSEcCtD
L-Arginine—Headache—Docetaxel—breast cancer	7.13e-05	0.000614	CcSEcCtD
L-Arginine—Anaphylactic shock—Doxorubicin—breast cancer	7.1e-05	0.000612	CcSEcCtD
L-Arginine—Vomiting—Capecitabine—breast cancer	7.01e-05	0.000603	CcSEcCtD
L-Arginine—Rash—Capecitabine—breast cancer	6.95e-05	0.000598	CcSEcCtD
L-Arginine—Dermatitis—Capecitabine—breast cancer	6.94e-05	0.000598	CcSEcCtD
L-Arginine—Tachycardia—Doxorubicin—breast cancer	6.93e-05	0.000597	CcSEcCtD
L-Arginine—Headache—Capecitabine—breast cancer	6.9e-05	0.000595	CcSEcCtD
L-Arginine—Hyperhidrosis—Doxorubicin—breast cancer	6.87e-05	0.000591	CcSEcCtD
L-Arginine—Anorexia—Doxorubicin—breast cancer	6.77e-05	0.000583	CcSEcCtD
L-Arginine—Nausea—Docetaxel—breast cancer	6.76e-05	0.000582	CcSEcCtD
L-Arginine—Decreased appetite—Epirubicin—breast cancer	6.67e-05	0.000575	CcSEcCtD
L-Arginine—Nausea—Capecitabine—breast cancer	6.54e-05	0.000564	CcSEcCtD
L-Arginine—Decreased appetite—Doxorubicin—breast cancer	6.17e-05	0.000532	CcSEcCtD
L-Arginine—Hypersensitivity—Methotrexate—breast cancer	6.04e-05	0.000521	CcSEcCtD
L-Arginine—Hypersensitivity—Epirubicin—breast cancer	5.66e-05	0.000487	CcSEcCtD
L-Arginine—Hypersensitivity—Doxorubicin—breast cancer	5.23e-05	0.000451	CcSEcCtD
L-Arginine—Vomiting—Methotrexate—breast cancer	5.21e-05	0.000449	CcSEcCtD
L-Arginine—Rash—Methotrexate—breast cancer	5.17e-05	0.000446	CcSEcCtD
L-Arginine—Dermatitis—Methotrexate—breast cancer	5.17e-05	0.000445	CcSEcCtD
L-Arginine—Headache—Methotrexate—breast cancer	5.14e-05	0.000443	CcSEcCtD
L-Arginine—Vomiting—Epirubicin—breast cancer	4.88e-05	0.00042	CcSEcCtD
L-Arginine—Nausea—Methotrexate—breast cancer	4.87e-05	0.00042	CcSEcCtD
L-Arginine—Rash—Epirubicin—breast cancer	4.84e-05	0.000417	CcSEcCtD
L-Arginine—Dermatitis—Epirubicin—breast cancer	4.84e-05	0.000417	CcSEcCtD
L-Arginine—Headache—Epirubicin—breast cancer	4.81e-05	0.000414	CcSEcCtD
L-Arginine—Nausea—Epirubicin—breast cancer	4.56e-05	0.000393	CcSEcCtD
L-Arginine—Vomiting—Doxorubicin—breast cancer	4.52e-05	0.000389	CcSEcCtD
L-Arginine—Rash—Doxorubicin—breast cancer	4.48e-05	0.000386	CcSEcCtD
L-Arginine—Dermatitis—Doxorubicin—breast cancer	4.47e-05	0.000385	CcSEcCtD
L-Arginine—Headache—Doxorubicin—breast cancer	4.45e-05	0.000383	CcSEcCtD
L-Arginine—Nausea—Doxorubicin—breast cancer	4.22e-05	0.000363	CcSEcCtD
L-Arginine—NOS3—Hemostasis—PIK3CB—breast cancer	1.1e-05	8.54e-05	CbGpPWpGaD
L-Arginine—SLC22A4—Transmembrane transport of small molecules—RAF1—breast cancer	1.09e-05	8.5e-05	CbGpPWpGaD
L-Arginine—ASL—Metabolism—PIK3CA—breast cancer	1.09e-05	8.45e-05	CbGpPWpGaD
L-Arginine—NOS3—Metabolism—FASN—breast cancer	1.08e-05	8.36e-05	CbGpPWpGaD
L-Arginine—SLC16A10—Transmembrane transport of small molecules—RAF1—breast cancer	1.08e-05	8.36e-05	CbGpPWpGaD
L-Arginine—NOS3—Metabolism—BCHE—breast cancer	1.07e-05	8.33e-05	CbGpPWpGaD
L-Arginine—NOS3—Disease—FGF10—breast cancer	1.07e-05	8.32e-05	CbGpPWpGaD
L-Arginine—NOS2—Disease—MTHFR—breast cancer	1.07e-05	8.28e-05	CbGpPWpGaD
L-Arginine—NOS2—Disease—TERT—breast cancer	1.06e-05	8.25e-05	CbGpPWpGaD
L-Arginine—NOS3—Metabolism—SLC5A5—breast cancer	1.06e-05	8.23e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—NOTCH4—breast cancer	1.05e-05	8.19e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—GZMB—breast cancer	1.05e-05	8.14e-05	CbGpPWpGaD
L-Arginine—NOS2—Hemostasis—MAPK3—breast cancer	1.05e-05	8.13e-05	CbGpPWpGaD
L-Arginine—NOS3—Disease—PDGFA—breast cancer	1.03e-05	8.03e-05	CbGpPWpGaD
L-Arginine—NOS2—Disease—FGFR1—breast cancer	1.03e-05	8.01e-05	CbGpPWpGaD
L-Arginine—ASS1—Metabolism—PIK3CB—breast cancer	1.02e-05	7.96e-05	CbGpPWpGaD
L-Arginine—NOS3—Metabolism—NQO1—breast cancer	1.02e-05	7.94e-05	CbGpPWpGaD
L-Arginine—NOS3—Metabolism—SLC2A1—breast cancer	1.02e-05	7.94e-05	CbGpPWpGaD
L-Arginine—NOS3—Disease—TGFBR2—breast cancer	1.02e-05	7.91e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—AGTR2—breast cancer	1.02e-05	7.9e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—CXCL2—breast cancer	1.02e-05	7.9e-05	CbGpPWpGaD
L-Arginine—NOS2—Disease—HIF1A—breast cancer	1.02e-05	7.89e-05	CbGpPWpGaD
L-Arginine—ASS1—Metabolism—PTGS2—breast cancer	1.02e-05	7.89e-05	CbGpPWpGaD
L-Arginine—NOS2—Hemostasis—TGFB1—breast cancer	1.02e-05	7.88e-05	CbGpPWpGaD
L-Arginine—NOS3—Hemostasis—IL2—breast cancer	1.01e-05	7.85e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—PTHLH—breast cancer	1.01e-05	7.81e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—BMP2—breast cancer	1.01e-05	7.81e-05	CbGpPWpGaD
L-Arginine—NOS3—Disease—ITPR1—breast cancer	1e-05	7.79e-05	CbGpPWpGaD
L-Arginine—NOS3—Metabolism—CYP3A4—breast cancer	9.98e-06	7.75e-05	CbGpPWpGaD
L-Arginine—NOS3—Disease—STAT5A—breast cancer	9.96e-06	7.73e-05	CbGpPWpGaD
L-Arginine—NOS3—Disease—ERBB4—breast cancer	9.96e-06	7.73e-05	CbGpPWpGaD
L-Arginine—NOS2—Disease—CAV1—breast cancer	9.83e-06	7.63e-05	CbGpPWpGaD
L-Arginine—NOS3—Metabolism—CYP1B1—breast cancer	9.81e-06	7.62e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—EDNRB—breast cancer	9.74e-06	7.57e-05	CbGpPWpGaD
L-Arginine—AZIN2—Metabolism—AKT1—breast cancer	9.72e-06	7.55e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—PGR—breast cancer	9.65e-06	7.49e-05	CbGpPWpGaD
L-Arginine—NOS3—Disease—SMAD4—breast cancer	9.64e-06	7.49e-05	CbGpPWpGaD
L-Arginine—NOS3—Metabolism—HSP90AA1—breast cancer	9.62e-06	7.47e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—THBS1—breast cancer	9.6e-06	7.45e-05	CbGpPWpGaD
L-Arginine—NOS3—Disease—HES1—breast cancer	9.42e-06	7.31e-05	CbGpPWpGaD
L-Arginine—NOS2—Hemostasis—KRAS—breast cancer	9.4e-06	7.3e-05	CbGpPWpGaD
L-Arginine—NOS3—Disease—NCOR1—breast cancer	9.36e-06	7.27e-05	CbGpPWpGaD
L-Arginine—NOS3—Metabolism—NCOA1—breast cancer	9.36e-06	7.27e-05	CbGpPWpGaD
L-Arginine—NOS3—Disease—FGF1—breast cancer	9.26e-06	7.19e-05	CbGpPWpGaD
L-Arginine—NOS3—Metabolism—STK11—breast cancer	9.22e-06	7.16e-05	CbGpPWpGaD
L-Arginine—NOS3—Metabolism—CYP19A1—breast cancer	9.22e-06	7.16e-05	CbGpPWpGaD
L-Arginine—NOS3—Disease—NRG1—breast cancer	9.19e-06	7.14e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—FLT1—breast cancer	9.16e-06	7.11e-05	CbGpPWpGaD
L-Arginine—NOS2—Disease—NOTCH1—breast cancer	9.16e-06	7.11e-05	CbGpPWpGaD
L-Arginine—NOS3—Disease—H2AFX—breast cancer	9.12e-06	7.09e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—FGF3—breast cancer	9.12e-06	7.08e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—SQSTM1—breast cancer	9.12e-06	7.08e-05	CbGpPWpGaD
L-Arginine—SLC22A5—Transmembrane transport of small molecules—ALB—breast cancer	9.1e-06	7.06e-05	CbGpPWpGaD
L-Arginine—ARG2—Metabolism—PIK3CA—breast cancer	9.01e-06	7e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—JAG1—breast cancer	9e-06	6.99e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—NOTCH3—breast cancer	8.97e-06	6.96e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—PARP1—breast cancer	8.97e-06	6.96e-05	CbGpPWpGaD
L-Arginine—NOS2—Disease—APC—breast cancer	8.95e-06	6.95e-05	CbGpPWpGaD
L-Arginine—NOS2—Disease—KIT—breast cancer	8.95e-06	6.95e-05	CbGpPWpGaD
L-Arginine—ASL—Metabolism—AKT1—breast cancer	8.89e-06	6.9e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—CALCA—breast cancer	8.86e-06	6.88e-05	CbGpPWpGaD
L-Arginine—ASS1—Metabolism—PTEN—breast cancer	8.86e-06	6.88e-05	CbGpPWpGaD
L-Arginine—NOS2—Disease—EGF—breast cancer	8.85e-06	6.87e-05	CbGpPWpGaD
L-Arginine—NOS3—Hemostasis—SRC—breast cancer	8.82e-06	6.85e-05	CbGpPWpGaD
L-Arginine—NOS3—Disease—ERCC2—breast cancer	8.8e-06	6.84e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—RPS6—breast cancer	8.75e-06	6.8e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—FGF4—breast cancer	8.68e-06	6.74e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—CXCL12—breast cancer	8.65e-06	6.72e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—CXCR4—breast cancer	8.65e-06	6.72e-05	CbGpPWpGaD
L-Arginine—NOS2—Hemostasis—PIK3CA—breast cancer	8.64e-06	6.71e-05	CbGpPWpGaD
L-Arginine—NOS3—Disease—ERBB3—breast cancer	8.61e-06	6.69e-05	CbGpPWpGaD
L-Arginine—NOS3—Disease—FGFR2—breast cancer	8.6e-06	6.68e-05	CbGpPWpGaD
L-Arginine—NOS3—Hemostasis—VEGFA—breast cancer	8.59e-06	6.67e-05	CbGpPWpGaD
L-Arginine—NOS3—Metabolism—COMT—breast cancer	8.57e-06	6.66e-05	CbGpPWpGaD
L-Arginine—NOS3—Metabolism—GSTP1—breast cancer	8.53e-06	6.63e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—PAK1—breast cancer	8.49e-06	6.59e-05	CbGpPWpGaD
L-Arginine—NOS2—Disease—BRAF—breast cancer	8.42e-06	6.54e-05	CbGpPWpGaD
L-Arginine—NOS3—Metabolism—HMOX1—breast cancer	8.42e-06	6.53e-05	CbGpPWpGaD
L-Arginine—NOS3—Metabolism—ITPR1—breast cancer	8.4e-06	6.52e-05	CbGpPWpGaD
L-Arginine—NOS2—Hemostasis—TP53—breast cancer	8.36e-06	6.49e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—TCF7L2—breast cancer	8.34e-06	6.48e-05	CbGpPWpGaD
L-Arginine—NOS3—Disease—MTHFR—breast cancer	8.27e-06	6.43e-05	CbGpPWpGaD
L-Arginine—NOS3—Disease—TERT—breast cancer	8.25e-06	6.41e-05	CbGpPWpGaD
L-Arginine—SLC22A5—Transmembrane transport of small molecules—RAF1—breast cancer	8.23e-06	6.39e-05	CbGpPWpGaD
L-Arginine—NOS2—Disease—AKT2—breast cancer	8.19e-06	6.36e-05	CbGpPWpGaD
L-Arginine—NOS3—Hemostasis—MAPK3—breast cancer	8.12e-06	6.31e-05	CbGpPWpGaD
L-Arginine—NOS3—Metabolism—ABCB1—breast cancer	8.08e-06	6.27e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—NOTCH2—breast cancer	8.04e-06	6.25e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—HSP90AA1—breast cancer	8.04e-06	6.25e-05	CbGpPWpGaD
L-Arginine—NOS3—Disease—FGFR1—breast cancer	8.01e-06	6.22e-05	CbGpPWpGaD
L-Arginine—NOS2—Hemostasis—HRAS—breast cancer	7.99e-06	6.21e-05	CbGpPWpGaD
L-Arginine—NOS3—Metabolism—TYMS—breast cancer	7.93e-06	6.16e-05	CbGpPWpGaD
L-Arginine—NOS3—Disease—HIF1A—breast cancer	7.89e-06	6.13e-05	CbGpPWpGaD
L-Arginine—NOS3—Hemostasis—TGFB1—breast cancer	7.88e-06	6.12e-05	CbGpPWpGaD
L-Arginine—NOS2—Disease—PIK3CD—breast cancer	7.87e-06	6.11e-05	CbGpPWpGaD
L-Arginine—NOS3—Metabolism—GSTM1—breast cancer	7.84e-06	6.09e-05	CbGpPWpGaD
L-Arginine—NOS3—Metabolism—NCOR1—breast cancer	7.84e-06	6.09e-05	CbGpPWpGaD
L-Arginine—NOS3—Metabolism—PLA2G4A—breast cancer	7.84e-06	6.09e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—PRL—breast cancer	7.82e-06	6.08e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—AGTR1—breast cancer	7.82e-06	6.08e-05	CbGpPWpGaD
L-Arginine—NOS2—Disease—SERPINE1—breast cancer	7.79e-06	6.05e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—ADAM10—breast cancer	7.71e-06	5.99e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—STK11—breast cancer	7.71e-06	5.99e-05	CbGpPWpGaD
L-Arginine—NOS3—Disease—CAV1—breast cancer	7.63e-06	5.93e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—PLG—breast cancer	7.62e-06	5.92e-05	CbGpPWpGaD
L-Arginine—NOS3—Metabolism—GPX1—breast cancer	7.51e-06	5.83e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—FGF10—breast cancer	7.5e-06	5.82e-05	CbGpPWpGaD
L-Arginine—NOS3—Metabolism—CYP1A1—breast cancer	7.43e-06	5.77e-05	CbGpPWpGaD
L-Arginine—NOS2—Disease—NOS3—breast cancer	7.43e-06	5.77e-05	CbGpPWpGaD
L-Arginine—NOS3—Metabolism—ERCC2—breast cancer	7.37e-06	5.72e-05	CbGpPWpGaD
L-Arginine—ARG2—Metabolism—AKT1—breast cancer	7.36e-06	5.72e-05	CbGpPWpGaD
L-Arginine—NOS3—Hemostasis—KRAS—breast cancer	7.3e-06	5.67e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—PDGFA—breast cancer	7.24e-06	5.62e-05	CbGpPWpGaD
L-Arginine—NOS3—Disease—NOS2—breast cancer	7.18e-06	5.57e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—TGFBR2—breast cancer	7.13e-06	5.54e-05	CbGpPWpGaD
L-Arginine—NOS3—Disease—NOTCH1—breast cancer	7.11e-06	5.52e-05	CbGpPWpGaD
L-Arginine—NOS2—Hemostasis—AKT1—breast cancer	7.06e-06	5.48e-05	CbGpPWpGaD
L-Arginine—NOS2—Disease—MDM2—breast cancer	7.05e-06	5.48e-05	CbGpPWpGaD
L-Arginine—NOS2—Disease—RAF1—breast cancer	7.03e-06	5.46e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—ITPR1—breast cancer	7.02e-06	5.45e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—ERBB4—breast cancer	6.97e-06	5.42e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—MMP3—breast cancer	6.97e-06	5.42e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—STAT5A—breast cancer	6.97e-06	5.42e-05	CbGpPWpGaD
L-Arginine—NOS2—Disease—ERBB2—breast cancer	6.95e-06	5.4e-05	CbGpPWpGaD
L-Arginine—NOS3—Disease—KIT—breast cancer	6.95e-06	5.4e-05	CbGpPWpGaD
L-Arginine—NOS3—Disease—APC—breast cancer	6.95e-06	5.4e-05	CbGpPWpGaD
L-Arginine—NOS3—Metabolism—MTHFR—breast cancer	6.93e-06	5.38e-05	CbGpPWpGaD
L-Arginine—NOS3—Disease—EGF—breast cancer	6.87e-06	5.34e-05	CbGpPWpGaD
L-Arginine—NOS2—Disease—PIK3CB—breast cancer	6.86e-06	5.33e-05	CbGpPWpGaD
L-Arginine—NOS2—Disease—MTOR—breast cancer	6.86e-06	5.33e-05	CbGpPWpGaD
L-Arginine—NOS2—Disease—CD4—breast cancer	6.85e-06	5.32e-05	CbGpPWpGaD
L-Arginine—NOS2—Disease—PTGS2—breast cancer	6.8e-06	5.28e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—SMAD4—breast cancer	6.75e-06	5.24e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—IGF1R—breast cancer	6.71e-06	5.21e-05	CbGpPWpGaD
L-Arginine—NOS3—Hemostasis—PIK3CA—breast cancer	6.71e-06	5.21e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—HES1—breast cancer	6.59e-06	5.12e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—PLA2G4A—breast cancer	6.56e-06	5.09e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—NCOR1—breast cancer	6.56e-06	5.09e-05	CbGpPWpGaD
L-Arginine—NOS3—Disease—BRAF—breast cancer	6.54e-06	5.07e-05	CbGpPWpGaD
L-Arginine—NOS3—Hemostasis—TP53—breast cancer	6.49e-06	5.04e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—CSF2—breast cancer	6.48e-06	5.03e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—FGF1—breast cancer	6.48e-06	5.03e-05	CbGpPWpGaD
L-Arginine—NOS2—Disease—CDKN1B—breast cancer	6.44e-06	5e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—NRG1—breast cancer	6.44e-06	5e-05	CbGpPWpGaD
L-Arginine—NOS3—Metabolism—CAV1—breast cancer	6.39e-06	4.96e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—H2AFX—breast cancer	6.39e-06	4.96e-05	CbGpPWpGaD
L-Arginine—NOS3—Disease—AKT2—breast cancer	6.36e-06	4.94e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—E2F1—breast cancer	6.34e-06	4.93e-05	CbGpPWpGaD
L-Arginine—ASS1—Metabolism—PIK3CA—breast cancer	6.25e-06	4.85e-05	CbGpPWpGaD
L-Arginine—NOS3—Hemostasis—HRAS—breast cancer	6.21e-06	4.82e-05	CbGpPWpGaD
L-Arginine—NOS3—Disease—PIK3CD—breast cancer	6.11e-06	4.75e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—SPP1—breast cancer	6.1e-06	4.73e-05	CbGpPWpGaD
L-Arginine—NOS2—Disease—CTNNB1—breast cancer	6.08e-06	4.72e-05	CbGpPWpGaD
L-Arginine—NOS3—Disease—SERPINE1—breast cancer	6.05e-06	4.69e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—ERBB3—breast cancer	6.03e-06	4.68e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—FGFR2—breast cancer	6.02e-06	4.67e-05	CbGpPWpGaD
L-Arginine—NOS2—Disease—CDKN1A—breast cancer	5.94e-06	4.61e-05	CbGpPWpGaD
L-Arginine—NOS2—Disease—PTEN—breast cancer	5.93e-06	4.6e-05	CbGpPWpGaD
L-Arginine—NOS3—Metabolism—PIK3CG—breast cancer	5.82e-06	4.52e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—TERT—breast cancer	5.78e-06	4.49e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—FGFR1—breast cancer	5.61e-06	4.36e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—HIF1A—breast cancer	5.53e-06	4.29e-05	CbGpPWpGaD
L-Arginine—NOS2—Disease—SRC—breast cancer	5.5e-06	4.27e-05	CbGpPWpGaD
L-Arginine—NOS3—Hemostasis—AKT1—breast cancer	5.48e-06	4.26e-05	CbGpPWpGaD
L-Arginine—NOS3—Disease—MDM2—breast cancer	5.48e-06	4.25e-05	CbGpPWpGaD
L-Arginine—NOS3—Disease—RAF1—breast cancer	5.46e-06	4.24e-05	CbGpPWpGaD
L-Arginine—NOS3—Disease—ERBB2—breast cancer	5.4e-06	4.19e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—LEP—breast cancer	5.39e-06	4.19e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—CAV1—breast cancer	5.34e-06	4.15e-05	CbGpPWpGaD
L-Arginine—NOS3—Disease—PIK3CB—breast cancer	5.33e-06	4.14e-05	CbGpPWpGaD
L-Arginine—NOS3—Disease—MTOR—breast cancer	5.33e-06	4.14e-05	CbGpPWpGaD
L-Arginine—NOS3—Disease—CD4—breast cancer	5.32e-06	4.13e-05	CbGpPWpGaD
L-Arginine—NOS2—Disease—STAT3—breast cancer	5.3e-06	4.12e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—KDR—breast cancer	5.29e-06	4.1e-05	CbGpPWpGaD
L-Arginine—NOS3—Disease—PTGS2—breast cancer	5.28e-06	4.1e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—ESR1—breast cancer	5.15e-06	4e-05	CbGpPWpGaD
L-Arginine—NOS3—Metabolism—PIK3CD—breast cancer	5.12e-06	3.97e-05	CbGpPWpGaD
L-Arginine—ASS1—Metabolism—AKT1—breast cancer	5.1e-06	3.96e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—FN1—breast cancer	5.09e-06	3.95e-05	CbGpPWpGaD
L-Arginine—NOS2—Disease—MAPK3—breast cancer	5.07e-06	3.93e-05	CbGpPWpGaD
L-Arginine—NOS3—Metabolism—ALB—breast cancer	5.05e-06	3.92e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—NFKBIA—breast cancer	5.03e-06	3.9e-05	CbGpPWpGaD
L-Arginine—NOS3—Disease—CDKN1B—breast cancer	5e-06	3.88e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—NOTCH1—breast cancer	4.98e-06	3.87e-05	CbGpPWpGaD
L-Arginine—NOS2—Disease—MYC—breast cancer	4.93e-06	3.83e-05	CbGpPWpGaD
L-Arginine—NOS2—Disease—TGFB1—breast cancer	4.91e-06	3.82e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—PIK3CG—breast cancer	4.87e-06	3.78e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—KIT—breast cancer	4.87e-06	3.78e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—APC—breast cancer	4.87e-06	3.78e-05	CbGpPWpGaD
L-Arginine—NOS2—Disease—EGFR—breast cancer	4.82e-06	3.74e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—EGF—breast cancer	4.81e-06	3.74e-05	CbGpPWpGaD
L-Arginine—NOS3—Disease—CTNNB1—breast cancer	4.72e-06	3.67e-05	CbGpPWpGaD
L-Arginine—NOS3—Disease—CDKN1A—breast cancer	4.61e-06	3.58e-05	CbGpPWpGaD
L-Arginine—NOS3—Disease—PTEN—breast cancer	4.6e-06	3.57e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—BRAF—breast cancer	4.58e-06	3.55e-05	CbGpPWpGaD
L-Arginine—NOS2—Disease—KRAS—breast cancer	4.55e-06	3.54e-05	CbGpPWpGaD
L-Arginine—NOS3—Metabolism—PIK3CB—breast cancer	4.46e-06	3.46e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—IGF1—breast cancer	4.46e-06	3.46e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—AKT2—breast cancer	4.45e-06	3.46e-05	CbGpPWpGaD
L-Arginine—NOS3—Metabolism—PTGS2—breast cancer	4.42e-06	3.43e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—PIK3CD—breast cancer	4.28e-06	3.32e-05	CbGpPWpGaD
L-Arginine—NOS3—Disease—SRC—breast cancer	4.27e-06	3.32e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—SERPINE1—breast cancer	4.23e-06	3.29e-05	CbGpPWpGaD
L-Arginine—NOS2—Disease—PIK3CA—breast cancer	4.18e-06	3.25e-05	CbGpPWpGaD
L-Arginine—NOS3—Disease—STAT3—breast cancer	4.12e-06	3.2e-05	CbGpPWpGaD
L-Arginine—NOS3—Disease—MAPK3—breast cancer	3.93e-06	3.05e-05	CbGpPWpGaD
L-Arginine—NOS2—Disease—HRAS—breast cancer	3.87e-06	3e-05	CbGpPWpGaD
L-Arginine—NOS3—Metabolism—PTEN—breast cancer	3.86e-06	2.99e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—MDM2—breast cancer	3.83e-06	2.98e-05	CbGpPWpGaD
L-Arginine—NOS3—Disease—MYC—breast cancer	3.83e-06	2.97e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—RAF1—breast cancer	3.82e-06	2.97e-05	CbGpPWpGaD
L-Arginine—NOS3—Disease—TGFB1—breast cancer	3.82e-06	2.96e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—RELA—breast cancer	3.8e-06	2.95e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—ERBB2—breast cancer	3.78e-06	2.94e-05	CbGpPWpGaD
L-Arginine—NOS3—Disease—EGFR—breast cancer	3.74e-06	2.91e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—MTOR—breast cancer	3.73e-06	2.9e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—PIK3CB—breast cancer	3.73e-06	2.9e-05	CbGpPWpGaD
L-Arginine—NOS2—Disease—IL6—breast cancer	3.7e-06	2.88e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—CXCL8—breast cancer	3.58e-06	2.78e-05	CbGpPWpGaD
L-Arginine—NOS3—Disease—KRAS—breast cancer	3.53e-06	2.74e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—CDKN1B—breast cancer	3.5e-06	2.72e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—CASP3—breast cancer	3.43e-06	2.66e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—IL2—breast cancer	3.43e-06	2.66e-05	CbGpPWpGaD
L-Arginine—NOS2—Disease—AKT1—breast cancer	3.42e-06	2.65e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—CCND1—breast cancer	3.34e-06	2.59e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—JUN—breast cancer	3.33e-06	2.59e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—CTNNB1—breast cancer	3.31e-06	2.57e-05	CbGpPWpGaD
L-Arginine—NOS3—Disease—PIK3CA—breast cancer	3.25e-06	2.52e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—MMP9—breast cancer	3.24e-06	2.52e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—CDKN1A—breast cancer	3.23e-06	2.51e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—PTEN—breast cancer	3.22e-06	2.5e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—MAPK8—breast cancer	3.15e-06	2.45e-05	CbGpPWpGaD
L-Arginine—NOS3—Disease—HRAS—breast cancer	3e-06	2.33e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—SRC—breast cancer	2.99e-06	2.32e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—VEGFA—breast cancer	2.91e-06	2.26e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—STAT3—breast cancer	2.88e-06	2.24e-05	CbGpPWpGaD
L-Arginine—NOS3—Disease—IL6—breast cancer	2.88e-06	2.23e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—MAPK3—breast cancer	2.75e-06	2.14e-05	CbGpPWpGaD
L-Arginine—NOS3—Metabolism—PIK3CA—breast cancer	2.72e-06	2.11e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—MYC—breast cancer	2.68e-06	2.08e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—TGFB1—breast cancer	2.67e-06	2.08e-05	CbGpPWpGaD
L-Arginine—NOS3—Disease—AKT1—breast cancer	2.65e-06	2.06e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—EGFR—breast cancer	2.62e-06	2.03e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—KRAS—breast cancer	2.48e-06	1.92e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—PIK3CA—breast cancer	2.27e-06	1.77e-05	CbGpPWpGaD
L-Arginine—NOS3—Metabolism—AKT1—breast cancer	2.22e-06	1.73e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—TP53—breast cancer	2.2e-06	1.71e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—HRAS—breast cancer	2.1e-06	1.63e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—IL6—breast cancer	2.01e-06	1.56e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—AKT1—breast cancer	1.86e-06	1.44e-05	CbGpPWpGaD
